TITAN PHARMACEUTICAL (TTP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (48)	4/25/1999 5:19:00 PM
From: scaram(o)uche	Read Replies (1) of 362

Miljenko: Is this the piv patent? Not much published lately about butyrate. butyrates useful for the treatment of cancer and other proliferative diseases Inventor(s): Rephaeli; Ada , Palo Alto, CA Nudelman; Abraham , Rehovot, Israel Applicant(s): Bar-Ilan University, Israel Kupat Holim Health Insurance Institution of the General Federation of Labor, Israel Issued/Filed Dates: Jan. 20, 1998 / Sept. 16, 1994 Application Number: US1994000306422 IPC Class: C07C 403/10; A61K 031/225; G01N 033/48; Class: 514/548; 554/221; 436/063; Field of Search: 554/221 514/548 Abstract: This invention relates to the novel compounds of Formula (I) and pharmaceutical compositions containing same, to methods of treating, preventing or ameliorating cancer and other proliferative diseases in a subject in need of such treatment comprising administering a compound of Formula (I) and pharmaceutically acceptable salts and prodrugs thereof. [Figure]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next